Dessislava I. Dimitrova

1.0k total citations · 1 hit paper
11 papers, 775 citations indexed

About

Dessislava I. Dimitrova is a scholar working on Hepatology, Epidemiology and Virology. According to data from OpenAlex, Dessislava I. Dimitrova has authored 11 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 5 papers in Epidemiology and 3 papers in Virology. Recurrent topics in Dessislava I. Dimitrova's work include Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and HIV Research and Treatment (3 papers). Dessislava I. Dimitrova is often cited by papers focused on Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and HIV Research and Treatment (3 papers). Dessislava I. Dimitrova collaborates with scholars based in United States, Germany and United Kingdom. Dessislava I. Dimitrova's co-authors include Claudia Martorell, David Gardiner, Robert Reindollar, Timothy Eley, Anna S. Lok, Megan Wind‐Rotolo, Eric Lawitz, C Pasquinelli, Fiona McPhee and Dennis M. Grasela and has published in prestigious journals such as New England Journal of Medicine, Hepatology and Journal of Hepatology.

In The Last Decade

Dessislava I. Dimitrova

11 papers receiving 753 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

2012 454 citations Anna S. Lok, David Gardiner et al. New England Journal of Medicine profile →

Peers

Dessislava I. Dimitrova

HEPAT

EPIDE

ID

RHEUM

MB

V. Carreño Spain

D. Hueppe Germany

C. Sarrazin Germany

Fernando E. Membreno United States

Minoru Horikita Japan

Vito Carretta Italy

E. Läwitz United States

Zu-Yau Lin Taiwan

Sue Ma United States

P.J. van Exel‐Oehlers Netherlands

V. Carreño Spain

Dessislava I. Dimitrova

880 ×1.3

HEPAT

864 ×1.5

EPIDE

98 ×0.6

ID

79 ×1.1

RHEUM

62 ×0.9

MB

Citations per year, relative to Dessislava I. Dimitrova Dessislava I. Dimitrova (= 1×) peers V. Carreño

Countries citing papers authored by Dessislava I. Dimitrova

Since Specialization

Citations

This map shows the geographic impact of Dessislava I. Dimitrova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dessislava I. Dimitrova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dessislava I. Dimitrova more than expected).

Fields of papers citing papers by Dessislava I. Dimitrova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dessislava I. Dimitrova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dessislava I. Dimitrova. The network helps show where Dessislava I. Dimitrova may publish in the future.

Co-authorship network of co-authors of Dessislava I. Dimitrova

This figure shows the co-authorship network connecting the top 25 collaborators of Dessislava I. Dimitrova. A scholar is included among the top collaborators of Dessislava I. Dimitrova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dessislava I. Dimitrova. Dessislava I. Dimitrova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Opsomer, Magda, Dessislava I. Dimitrova, Simon Vanveggel, et al.. (2018). Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir. Drugs in R&D. 18(3). 199–210. 9 indexed citations

2.

Fredlund, Paul, Jan Hillson, Todd Gray, et al.. (2015). Peginterferon Lambda-1a Is Associated with a Low Incidence of Autoimmune Thyroid Disease in Chronic Hepatitis C. Journal of Interferon & Cytokine Research. 35(11). 841–843. 5 indexed citations

3.

Ahmad, Tariq, Philip D. Yin, Jeffrey E. Saffitz, et al.. (2014). Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C. Hepatology. 62(2). 409–416. 56 indexed citations

4.

Fontana, Robert J., Eric Hughes, Marc Bifano, et al.. (2013). Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C. American Journal of Transplantation. 13(6). 1601–1605. 112 indexed citations

5.

Jacobson, Ira M., et al.. (2013). 1203 SAFETY PROFILE OF DACLATASVIR IN COMBINATION WITH PEGINTERFERON alfa AND RIBAVIRIN IN 1100 PATIENTS WITH CHRONIC HCV INFECTION TREATED IN PHASE 2 STUDIES. Journal of Hepatology. 58. S489–S489. 5 indexed citations

6.

Fontana, Robert J., Eric Hughes, Henry D. Appelman, et al.. (2012). Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation. Liver Transplantation. 18(9). 1053–1059. 51 indexed citations

7.

Lok, Anna S., David Gardiner, Eric Lawitz, et al.. (2012). Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1. New England Journal of Medicine. 366(3). 216–224. 454 indexed citations breakdown →

8.

Lok, Anna S., David Gardiner, Eric Lawitz, et al.. (2011). 1356 QUADRUPLE THERAPY WITH BMS-790052, BMS-650032 AND PEG-IFN/RBV FOR 24 WEEKS RESULTS IN 100% SVR12 IN HCV GENOTYPE 1 NULL RESPONDERS. Journal of Hepatology. 54. S536–S536. 48 indexed citations

9.

Dimitrova, Dessislava I., Nancy L. Reichenbach, Xiaowei Yang, et al.. (2007). Inhibition of HIV Type 1 Replication in CD4 ⁺ and CD14 ⁺ Cells Purified from HIV Type 1-Infected Individuals by the 2-5A Agonist Immunomodulator, 2-5A ^N6B. AIDS Research and Human Retroviruses. 23(1). 123–134. 13 indexed citations

10.

Dimitrova, Dessislava I., et al.. (2007). Polysomnography Versus Home Sleep Study: Overview and Clinical Application. Atlas of the Oral and Maxillofacial Surgery Clinics. 15(2). 101–109. 3 indexed citations

11.

Dimitrova, Dessislava I., Xiaowei Yang, Nancy L. Reichenbach, et al.. (2005). Lentivirus-Mediated Transduction of PKR into CD34 ⁺ Hematopoietic Stem Cells Inhibits HIV-1 Replication in Differentiated T Cell Progeny. Journal of Interferon & Cytokine Research. 25(6). 345–360. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact